https://lnkd.in/eGrEkihW, Drexel University Alumni's 40 Under 40 https://lnkd.in/eJK-PRMH Contact Us| When leaders of private biotech and pharmaceutical companies and their in-house counsel are contemplating a reverse merger or SPAC merger as an IPO alternative, they must be cognizant of the pros and cons of each so they can avoid doing more harm than good to their company's valuation, reputation, and prospects. While a SPAC initially raises a significant amount of capital in its IPO, SPAC IPO investors have the right, in connection with a later proposed merger, to have their shares redeemed by the SPAC, which depletes the cash held in trust for the company that merges with the SPAC. Join us in congratulatingJennifer Porter- Partner inTroutman Pepper's Health Sciences Department. Congratulations! How receptive have sponsors been to the various guidance and what. Jill Beck Runs for Pennsylvania Superior Court, Judge Matthew Wolf Runs for Commonwealth Court, Longtime Paul Hastings CFO Departs Following Wave of Exits, Judge Rejects Motion by Trump Lawyers for Mistrial in Civil Rape Case, Bryan Neft Runs for the Commonwealth Court. Troutman Pepper was proud to sponsor and speak at the ACC Greater Philadelphia In-House Counsel Conference. When expanded it provides a list of search options that will switch the search inputs to match the current selection. Angela tells us about her secret life as a detective and why being able to say she gave her all to a client is so rewarding. There are limited manufacturers with the expertise and facilities to manufacture cell and gene therapy products. Given these challenges, ATMP sponsors are now implementing cost-saving strategies to extend cash runways, which can, among other strategies, include limiting development focus to one or two programs at a time.In addition, ATMP sponsors are looking for more creative financing alternatives, such as strategic collaborations with large pharma partners, royalty financing, venture debt and support from inside investors, to get them through until the markets rebound. Wealth Management Banker, Vice President - Legal Specialty Group at Wells Fargo Private Bank, NMLSR ID: 685248, Business Development Manager at Troutman Pepper, Senior Business Developer at AmLaw 50 Law Firm. Porter: Philadelphias Cellicon Valley continues to grow. Investors today are more discerning after witnessing several companies suffer from development setbacks or failures after their IPOs, and are now looking for ways to derisk, such as by investing in companies developing multiple products or products that can treat multiple indications, to afford more "shots on goal.". This process also usually entails private companies competing in an auction process with respect to their valuations and post-merger equity splits, and with respect to their ability to raise a PIPE to ensure a sufficient cash runway.